Full Press Release Details
Bioanalytical Systems, Inc.
Announces Appointment of New Chief Financial Officer
WEST LAFAYETTE, IN -
May 11, 2016 -- Bioanalytical Systems, Inc. (NASDAQ:BASI) ("BASi" or the "Company") on May 9, 2016,
the Board of Directors of the Company approved the appointment of Jill C. Blumhoff, age 39, as Chief Financial Officer (CFO)
and Vice President of Finance of the Company. Ms. Blumhoff succeeds Jeffrey Potrzebowski, age 63, effective with his retirement
from the Company on May 9, 2016.
Ms. Blumhoff joined BASi in
October 2007 as Assistant Controller and has served as Director of Finance, Tax and IT since 2013. In her role, Ms. Blumhoff has
been responsible for all aspects of financial reporting and disclosure in addition to leading the Company's efforts in building
the financial support structure at BASi. Before joining BASi, Ms. Blumhoff held various roles of increasing responsibility in financial
reporting and analysis at Wabash National Corporation, in Lafayette Indiana. Ms. Blumhoff began her career at Ernst & Young
LLP. She earned a Bachelor of Science degree in accounting from the University of Illinois at Urbana-Champaign.
"Jill is a valued member
of the finance team who has been instrumental in guiding BASi during a period of significant change at our Company," said
Jacqueline M. Lemke, BASi President & Chief Executive Officer. "Jill's knowledge and understanding of BASi's
business as well as her leadership of the financial team in support all areas of the operations, will enable BASi to focus on our
highest-potential growth opportunities."
"Mr. Potrzebowski came
to BASi in June of 2014 with a wealth of prior experience and did an excellent job as a senior leader both managing the financial
team and contributing to all aspects of the Company. I would like to thank him for his hard work and dedication and wish him well
in his future endeavors," said Jacqueline M. Lemke, BASi President & Chief Executive Officer.
Mr. Potrzebowski will be available
to consult with Ms. Blumhoff in order to ensure a seamless transition.
About Bioanalytical Systems, Inc.
BASi is a pharmaceutical development
company providing contract research services and monitoring instruments to the world's leading drug development companies and medical
research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce
the cost of taking a new drug to market. Visit www.BASinc.com for more about BASi.
This release may contain forward-looking
statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes
in the market and demand for our products and services, the development, marketing and sales of products and services, changes
in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings
with the Securities and Exchange Commission.